Robyn Strong
Chief Executive Officer
Robyn works closely with the ANZCHOG Board, developing and operationalising ANZCHOG's strategic plan. Robyn provides oversight to all of ANZCHOG's office activities and is responsible for establishing and maintaining relationships with ANZCHOG's national and international partners and supporters. She provides overarching management of ANZCHOG-sponsored trial activity.
Annette Dempsey
National Trial Manager
Annette provides high level quality oversight of ANZCHOG sponsored clinical trials. She provides ongoing trial management support throughout the clinical trial life cycle, liaising with our international sponsor partners including through early study development activities, providing logistical/study operational planning, project management and problem solving expertise.
Dr Jasper de Boer
Grants and Partnership Manager
Jasper is responsible for researching, developing and finalising compelling and persuasive high quality grant funding applications and proposals for competitive and targeted grant opportunities that support ANZCHOG’s clinical trial/ research program. Additionally Jasper will develop and maintaining collaborative relationships and mutually beneficial partnerships with government, non-government and funding organisations.
Nicole Fairweather
Clinical Trial Monitor
As Clinical Trial Monitor Nicole is responsible for all on-site monitoring activities related to ANZCHOG sponsored trials. She ensures that they are conducted, recorded and reported in accordance with the protocol, standard operating procedures, good clinical practice and other applicable regulations.
Dr Kathryn Kinross
National Study Coordinator
Kathryn is responsible for the central coordination and conduct of five ANZCHOG-sponsored trials; ReRAD, CIRCAA, Glo-BNHL, AIM BRAIN PROject and EuroNet. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met. Additionally, she coordinates ANZCHOG projects such as the National Minimum Dataset project and CIRCAA.
Matthew Ivers
National Study Coordinator
Matt is responsible for the central coordination and conduct of four ANZCHOG-sponsored trials; FaR-RMS, TiNT, MetMED and REGO-EWING. He is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Rosie Newman
National Study Coordinator
Rosie is responsible for the central coordination and conduct of seven ANZCHOG-sponsored trials; SJ-ELiOT, PNOC022, PNOC019, CONNECT1903, CONNECT1905, CONNECT2108 and PNOC029 trials. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Ciara Tremblay
National Study Coordinator
Ciara is responsible for the central coordination and conduct of four ANZCHOG-sponsored trials; VICTORY, BEACON2, Interfant-21 and NORTH. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met. Ciara is also responsible for the onsite monitoring of the ZERO2 study.
Lucy Romanoff
National Study Coordinator
Lucy is responsible for the central coordination and conduct of three ANZCHOG-sponsored trials; RAVEN, INTER-EWING1 and rEECur. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Sharina Omerovic
Clinical Trial Start-Up Specialist
Sharina is involved in the national start-up of ANZCHOG-sponsored trials, specifically the preparation and coordination of submissions to ethics, regulatory, and other bodies. Sharina assists with the early development and planning activities, reviews feasibility analyses, and provides input into logistics and operational planning.
Alex McKellar
National Study Coordinator
Alex is responsible for the central coordination and conduct of four ANZCHOG-sponsored trials; MyeChild, EuroNet, LGG Avastin and IntReALL SR. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Kylie May
Project & Grants Officer
Kylie assists in the management of ANZCHOG’s research grants portfolio, including contract development, meeting grant deliverables and liaising closely with the Monash Research Office, Principal Investigators and National Trial Coordinators. She is also responsible for project-specific work, such as the establishment and administration of the ANZCHOG digital platform for members.
Sara Field
Business & Finance Officer
Sara acts as the main point of contact for the ANZCHOG office, coordinating the day-to-day administration. She manages the ANZCHOG disease and discipline groups and is responsible for providing financial management of ANZCHOG's portfolio. She also coordinates ANZCHOG projects such as the clinical trial registry and the FMFC Brain Cancer Clinical Trials Program. Additionally, she provides operational support for the ANZCHOG Annual Scientific Meeting.
Penny Molnar
Communications and Media Manager
Penny is responsible for the development and implementation of ANZCHOG’s communication strategy, including internal activities (newsletters, ANZCHOG Connect platform) and external communications (including media releases, website, social media platforms and content generation).